Series on pharmacology in practice. I. Drugs that alter mood. II. Lithium

A. H. Rosenbaum, T. Maruta, E. Richelson

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

In the last two decades, there has been rapid progress in the pharmacologic treatment of affective disorders. In Part 1 of this review, drugs mainly used for depression (tricyclic antidepressants and monosamine oxidase inhibitors) were discussed. Here, lithium carbonate, the most effective drug for manic-depressive illness (bipolar depression) is the focus. Its indications, mode of action, pharmacokinetics, dosage, and side effects are discussed. A section on drug interactions with lithium deals with the combination effect of lithium used with antidepressant and other psychotropic agents.

Original languageEnglish (US)
Pages (from-to)401-407
Number of pages7
JournalMayo Clinic Proceedings
Volume54
Issue number6
StatePublished - 1979

Fingerprint

Lithium
Pharmacology
Lithium Carbonate
Tricyclic Antidepressive Agents
Mood Disorders
Drug Interactions
Bipolar Disorder
Pharmaceutical Preparations
Antidepressive Agents
Oxidoreductases
Pharmacokinetics
Depression
Major Affective Disorder 2

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rosenbaum, A. H., Maruta, T., & Richelson, E. (1979). Series on pharmacology in practice. I. Drugs that alter mood. II. Lithium. Mayo Clinic Proceedings, 54(6), 401-407.

Series on pharmacology in practice. I. Drugs that alter mood. II. Lithium. / Rosenbaum, A. H.; Maruta, T.; Richelson, E.

In: Mayo Clinic Proceedings, Vol. 54, No. 6, 1979, p. 401-407.

Research output: Contribution to journalArticle

Rosenbaum, AH, Maruta, T & Richelson, E 1979, 'Series on pharmacology in practice. I. Drugs that alter mood. II. Lithium', Mayo Clinic Proceedings, vol. 54, no. 6, pp. 401-407.
Rosenbaum, A. H. ; Maruta, T. ; Richelson, E. / Series on pharmacology in practice. I. Drugs that alter mood. II. Lithium. In: Mayo Clinic Proceedings. 1979 ; Vol. 54, No. 6. pp. 401-407.
@article{d1646dcd39f84b8a8cd9f1320b84e4ae,
title = "Series on pharmacology in practice. I. Drugs that alter mood. II. Lithium",
abstract = "In the last two decades, there has been rapid progress in the pharmacologic treatment of affective disorders. In Part 1 of this review, drugs mainly used for depression (tricyclic antidepressants and monosamine oxidase inhibitors) were discussed. Here, lithium carbonate, the most effective drug for manic-depressive illness (bipolar depression) is the focus. Its indications, mode of action, pharmacokinetics, dosage, and side effects are discussed. A section on drug interactions with lithium deals with the combination effect of lithium used with antidepressant and other psychotropic agents.",
author = "Rosenbaum, {A. H.} and T. Maruta and E. Richelson",
year = "1979",
language = "English (US)",
volume = "54",
pages = "401--407",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "6",

}

TY - JOUR

T1 - Series on pharmacology in practice. I. Drugs that alter mood. II. Lithium

AU - Rosenbaum, A. H.

AU - Maruta, T.

AU - Richelson, E.

PY - 1979

Y1 - 1979

N2 - In the last two decades, there has been rapid progress in the pharmacologic treatment of affective disorders. In Part 1 of this review, drugs mainly used for depression (tricyclic antidepressants and monosamine oxidase inhibitors) were discussed. Here, lithium carbonate, the most effective drug for manic-depressive illness (bipolar depression) is the focus. Its indications, mode of action, pharmacokinetics, dosage, and side effects are discussed. A section on drug interactions with lithium deals with the combination effect of lithium used with antidepressant and other psychotropic agents.

AB - In the last two decades, there has been rapid progress in the pharmacologic treatment of affective disorders. In Part 1 of this review, drugs mainly used for depression (tricyclic antidepressants and monosamine oxidase inhibitors) were discussed. Here, lithium carbonate, the most effective drug for manic-depressive illness (bipolar depression) is the focus. Its indications, mode of action, pharmacokinetics, dosage, and side effects are discussed. A section on drug interactions with lithium deals with the combination effect of lithium used with antidepressant and other psychotropic agents.

UR - http://www.scopus.com/inward/record.url?scp=0018772153&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018772153&partnerID=8YFLogxK

M3 - Article

C2 - 449409

AN - SCOPUS:0018772153

VL - 54

SP - 401

EP - 407

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 6

ER -